LauraMichelleNadeauMD

Oncology • Royal Oak, MI

Assistant Professor, Internal Medicine, Oakland University Wm Beaumont SOM

Join to view full profile

Dr. Nadeau is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nadeau's full profile

Already have an account?

Office
3577 W 13 Mile Rd
Ste 103
Royal Oak, MI 48073
Phone+1 248-288-4500

Fax+1 248-288-0450

Education & Training

Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1999 - 2002
Case Western Reserve University School of MedicineClass of 1999

Certifications & Licensure

MI State Medical License 2005 - 2027
OH State Medical License 1999 - 2006
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence Start of enrollment: 2011 Nov 01
Completed
Phase 3

Publications & Presentations

PubMed

1 citations
Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors.
Mats Någård, Mei-Lin Ah-See, James Strauss, Trisha Wise-Draper, Howard P Safran
Cancer Chemotherapy and Pharmacology. 2023-09-01
Adavosertib (AZD1775) does not prolong the QTc interval in patients with advanced solid tumors: a phase I open-label study.
Mats Någård, Mei-Lin Ah-See, James Strauss, Trisha Wise-Draper, Howard P Safran
Cancer Chemotherapy and Pharmacology. 2023-08-01
11 citations
Outcomes According to Breast Cancer Subtype in Patients Treated With Accelerated Partial Breast Irradiation
J. Ben Wilkinson, Chirag Shah, Mitual Amin, Laura Nadeau, Simona F. Shaitelman
Clinical Breast Cancer. 2017-02-01

Press Mentions

Phase 2 Study of Duvelisib in Previously Treated Patients with Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (BRIO)December 12th, 2017